rs281864846
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PP3_StrongPP5_Very_Strong
The NM_000517.6(HBA2):c.179G>A(p.Gly60Asp) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G60V) has been classified as Likely benign.
Frequency
Genomes: not found (cov: 18)
Exomes 𝑓: 9.8e-7 ( 0 hom. )
Consequence
HBA2
NM_000517.6 missense
NM_000517.6 missense
Scores
9
5
2
Clinical Significance
Conservation
PhyloP100: 6.26
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.993
PP5
Variant 16-173208-G-A is Pathogenic according to our data. Variant chr16-173208-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 439112.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBA2 | NM_000517.6 | c.179G>A | p.Gly60Asp | missense_variant | 2/3 | ENST00000251595.11 | NP_000508.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBA2 | ENST00000251595.11 | c.179G>A | p.Gly60Asp | missense_variant | 2/3 | 1 | NM_000517.6 | ENSP00000251595 | P1 | |
HBA2 | ENST00000484216.1 | c.149G>A | p.Gly50Asp | missense_variant | 2/2 | 1 | ENSP00000495899 | |||
HBA2 | ENST00000482565.1 | n.315G>A | non_coding_transcript_exon_variant | 1/2 | 1 | |||||
HBA2 | ENST00000397806.1 | c.83G>A | p.Gly28Asp | missense_variant | 2/3 | 2 | ENSP00000380908 |
Frequencies
GnomAD3 genomes Cov.: 18
GnomAD3 genomes
Cov.:
18
GnomAD4 exome AF: 9.76e-7 AC: 1AN: 1024858Hom.: 0 Cov.: 14 AF XY: 0.00000192 AC XY: 1AN XY: 519910
GnomAD4 exome
AF:
AC:
1
AN:
1024858
Hom.:
Cov.:
14
AF XY:
AC XY:
1
AN XY:
519910
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 18
GnomAD4 genome
Cov.:
18
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 09, 2023 | The Hb Adana variant (HBA2: c.179G>A; p.Gly60Asp, also known as Gly59Asp when numbered from the mature protein, rs281864846, HbVar ID: 87) is reported in the literature in multiple individuals with alpha-thalassemia, Hb H disease, and hydrops fetalis usually in combination with other pathogenic variants and is often associated with a severe course of disease (see HbVar and references therein, Alauddin 2014 and 2018, Megawati 2014, Nainggolan 2010, Singh 2018). This variant is reported as highly unstable (see HbVar). This variant is reported in ClinVar (Variation ID: 439112) and is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. Computational analyses predict that this variant is deleterious (REVEL: 0.867). Based on available information, this variant is considered to be pathogenic. References: Link to HbVar database: https://globin.bx.psu.edu/hbvar/menu.html Alauddin H et al. A case series of a-thalassemia intermedia due to compound heterozygosity for Hb Adana (HBA2: c179G>A (or HBA1); p.Gly60Asp) with other alpha-thalassemias in Malay families. Hemoglobin. 2014;38(4):277-81. PMID: 24829075. Alauddin H et al. A Unique Interaction of IVS-I-1 (G>A) (HBA2: c.95+1G>A) with Hb Adana (HBA2: c.179G>A) Presenting as Transfusion-Dependent alpha-Thalassemia. Hemoglobin. 2018 Jul;42(4):247-251. PMID: 30623696. Megawati D et al. Severe alpha-thalassemia intermedia due to a compound heterozygosity for the highly unstable Hb Adana (HBA2: c.179G>A) and a novel codon 24 (HBA2: c.75T>A) mutation. Hemoglobin. 2014;38(2):149-51. PMID: 24351118. Nainggolan IM et al. Hydrops fetalis associated with homozygosity for Hb Adana (alpha59(E8)Gly-->Asp (alpha2)). Hemoglobin. 2010;34(4):394-401. PMID: 20642338. Singh SA et al. Hb Adana (HBA2 or HBA1: c.179G > A) and alpha thalassemia: Genotype-phenotype correlation. Pediatr Blood Cancer. 2018 Sep;65(9):e27220. PMID: 29749692. - |
Pathogenic, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | May 03, 2023 | The variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). In the published literature, the variant protein is described as being unstable and as having a range of mild to severe presentations of alpha thalassemia in multiple individuals with different deletional and non-deletional pathogenic variants (PMIDs: 9029003 (1997), 20642338 (2010), 27271331 (2016), 29749692 (2018), 33364739 (2020)). Based on the available information, this variant is classified as pathogenic. - |
alpha Thalassemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 21, 2023 | Variant summary: HBA2 c.179G>A (p.Gly60Asp) (also known as Gly59Asp/ Hb Adana ) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 131276 control chromosomes (gnomAD). c.179G>A has been reported in the literature in multiple individuals affected with alpha-thalassemia and hydrops fetalis (examples:Curuk_1993, Nainggolan_2010, Megawati_2014, and Alauddin_2014). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 8237999, 20642338, 24351118, 24829075). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Non-immune hydrops fetalis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genomic Medicine Lab, University of California San Francisco | Dec 10, 2020 | - - |
HEMOGLOBIN H HYDROPS FETALIS SYNDROME Other:1
other, no assertion criteria provided | literature only | OMIM | Sep 12, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Pathogenic
D
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Vest4
MutPred
Gain of ubiquitination at K62 (P = 0.0525);.;
MVP
MPC
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at